Are high-velocity tricuspid and pulmonary regurgitation endocarditis risk substrates?

被引:10
作者
Dodo, H
Perloff, JK
Child, JS
Miner, PD
Pegues, DA
机构
[1] Univ Calif Los Angeles, Div Cardiol, Ctr Hlth Sci, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Div Infect Dis, Dept Med, Los Angeles, CA USA
[3] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA USA
[4] Univ Calif Los Angeles, Adult Congenital Heart Dis Ctr, Los Angeles, CA USA
关键词
D O I
10.1016/S0002-8703(98)70190-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background A major predisposing cause of infective endocarditis is a susceptible cardiac substrate characterized by high-velocity turbulent flow. However, the risk incurred by high-pressure, high-velocity regurgitation across inherently normal pulmonary and tricuspid valves has not hitherto been examined. Methods and Results This study focused on 186 adult patients with congenital heart disease who had pulmonary vascular disease and inherently normal right-sided pulmonary and tricuspid valves. The observation period was approximately 1646 patient-years. Exclusion criteria were coexisting lesions that might have served as independent risk substrates for infective endocarditis. High-velocity turbulent pulmonary and tricuspid regurgitation were identified and quantified by color flow imaging and continuous wave Doppler echocardiography. Diagnoses of infective endocarditis were based on established clinical and laboratory criteria. Tricuspid regurgitation was moderate to severe in 80 patients and mild or absent in 106 patients. Pulmonary regurgitation was moderate to severe in 84 patients and mild or absent in 102 patients. With the exception of a single habitual intravenous drug abuser, no patient, irrespective of the degree of high-velocity turbulent pulmonary or tricuspid regurgitation, had infective endocarditis. Conclusions High-velocity turbulent flow across inherently normal pulmonary and tricuspid valves rendered incompetent by pulmonary hypertension may represent a relatively low-risk or no-risk substrate for infective endocarditis.
引用
收藏
页码:109 / 114
页数:6
相关论文
共 24 条
[1]  
CHILD JS, 1998, CONGENITAL HEART DIS, P129
[2]  
CORONE P, 1989, ARCH MAL COEUR VAISS, V82, P779
[3]  
Dajani AS, 1997, CIRCULATION, V96, P358
[4]   INFECTIVE ENDOCARDITIS IN OPIATE ADDICTS - ANALYSIS OF 80 CASES STUDIED AT NECROPSY [J].
DRESSLER, FA ;
ROBERTS, WC .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 63 (17) :1240-1257
[5]   DRUG-THERAPY - PREVENTION OF INFECTIVE ENDOCARDITIS [J].
DURACK, DT .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (01) :38-44
[6]  
GERSONY WM, 1993, CIRCULATION, V87, P121
[7]   EPIDEMIOLOGIC ASPECTS OF INFECTIVE ENDOCARDITIS IN AN URBAN-POPULATION - A 5-YEAR PROSPECTIVE-STUDY [J].
HOGEVIK, H ;
OLAISON, L ;
ANDERSSON, R ;
LINDBERG, J ;
ALESTIG, K .
MEDICINE, 1995, 74 (06) :324-339
[8]  
KOZAK LJ, 1983, DHHS PUBLICATION
[9]  
Kubak Bernard M., 1996, Cardiology Clinics, V14, P405, DOI 10.1016/S0733-8651(05)70293-9
[10]  
LAWRENCE L, 1984, DHHS PUBLICATION PHS